With its fourth fund, the medical technology investor SHS Gesellschaft für Beteiligungsmanagement from Tübingen has acquired a majority share in SIS Medical AG and SCHWAGER MEDICA AG (SIS-SCHWAGER Group). The Group develops, produces and distributes products for the treatment of vascular disease.
